Is Now The TIme To Buy Stock In Moderna, GameStop, AMC Or Express?
One of the most common questions traders have about stocks is “Why Is It Moving?”.
That’s why Benzinga created the Why Is It Moving, or WIIM, feature in Benzinga Pro. WIIMs are a one-sentence description as to why that stock is moving.
Here’s why shares of Moderna, GameStop, AMC and Express are moving.
Moderna Inc (NASDAQ: MRNA) shares are trading higher following a report suggesting the German Health Minister said the EU will order more COVID-19 vaccines from Moderna.
Moderna is a clinical-stage biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, and cardiovascular diseases. The company has been at the forefront of COVID-19 vaccine research and development.
GameStop Corp. (NYSE: GME), AMC Entertainment Holdings Inc (NYSE: AMC) and Express, Inc. (NYSE: EXPR) shares are trading higher in Friday’s premarket session amid continued momentum driven by retail investor interest in the stocks.
The stocks spiked Thursday after hours after Robinhood said it would allow limited buying on Friday's trading session.
GameStop operates as a multichannel video game, consumer electronics, and collectibles retailer in the United States, Canada, Australia, and Europe.
AMC is a movie theatre chain. As of March 17, 2020, it operated approximately 1,000 theatres and 11,000 screens in the United States and internationally.
Earlier this week, AMC said it raised or signed commitment letters to receive $917 million of new equity and debt capital. The capital infusion will allow the company to "make it through this dark coronavirus-impacted winter."
Express, Inc. operates as an apparel and accessories retailer. As of Oct. 31, 2020, the company operated 592 stores comprising 378 retail stores and 214 factory outlet stores in the United States and Puerto Rico, as well as an online store.
See more from Benzinga
© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
